Patents by Inventor Kenneth M. HUTTNER

Kenneth M. HUTTNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intra-amniotic administration of EDI200 for the treatment of ectodermal dysplasias
    Patent number: 10300013
    Abstract: The invention relates to methods for the intra-amniotic administration of EDA agonists, in particular EDI200. Use of the methods described allow for the design of targeted therapeutic dosing and administration regimens in order to correct or alter abnormal phenotypes associated with ectodermal dysplasias, in particular, XLHED.
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: May 28, 2019
    Assignees: EspoirXLHED Sàrl, FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERG
    Inventors: Pascal Schneider, Kenneth M. Huttner, Neil Kirby, Holm Schneider
  • DETECTING GENETIC PREDISPOSITION TO OSTEOARTHRITIS ASSOCIATED CONDITIONS
    Publication number: 20160340734
    Abstract: This application relates to methods and kits for detecting predisposition to increased risk for osteoarthritis associated conditions.
    Type: Application
    Filed: August 10, 2016
    Publication date: November 24, 2016
    Inventors: Jack F. BUKOWSKI, Nazneen AZIZ, Hwa-Ying WANG, Kenneth M. HUTTNER, Mukundan ATTUR, Steven B. ABRAMSON
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF ECTODERMAL DYSPLASIA
    Publication number: 20160272694
    Abstract: The invention relates to pharmaceutical compositions and methods for the treatment of ectodermal displasias via the administration of EDA agonists, in particular EDI200. Use of the compositions and methods described allow for therapeutic dosing and administration regimens in human patients to correct or alter abnormal phenotypes associated with genetic disorders, in particular, XLHED.
    Type: Application
    Filed: November 13, 2013
    Publication date: September 22, 2016
    Inventors: Kenneth M. Huttner, Neil Kirby, Jr., Pascal Schneider, Olivier Gaide
  • INTRA-AMNIOTIC ADMINISTRATION OF PROTEINS FOR THE TREATMENT OF ECTODERMAL DYSPLASIAS
    Publication number: 20160271055
    Abstract: The invention relates to methods for the intra-amniotic administration of EDA agonists, in particular EDI200. Use of the methods described allow for the design of targeted therapeutic dosing and administration regimens in order to correct or alter abnormal phenotypes associated with ectodermal dysplasias, in particular, XLHED.
    Type: Application
    Filed: October 21, 2014
    Publication date: September 22, 2016
    Inventors: Pascal SCHNEIDER, Kenneth M. HUTTNER, Neil KIRBY, Holm SCHNEIDER